Projected Income Statement: Celltrion, Inc.

Forecast Balance Sheet: Celltrion, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -476 236 1,310 1,165 2,571 2,224 1,371 494
Change - 149.58% 455.08% -11.07% 120.69% -13.49% -38.35% -63.97%
Announcement Date 16/02/22 03/03/23 29/02/24 25/02/25 04/02/26 - - -
1KRW in Billions
Estimates

Cash Flow Forecast: Celltrion, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 63.38 111.2 210 135.1 108.2 222.3 248.4 205.2
Change - 75.4% 88.94% -35.7% -19.87% 105.38% 11.75% -17.41%
Free Cash Flow (FCF) 1 589,594 -110,305 327,112 766,812 537,827 1,013,086 1,340,953 1,561,440
Change - -118.71% 396.55% 134.42% -29.86% 88.37% 32.36% 16.44%
Announcement Date 16/02/22 03/03/23 29/02/24 25/02/25 04/02/26 - - -
1KRW in Million
Estimates

Forecast Financial Ratios: Celltrion, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 51.41% 38.25% 41.22% 25.59% 34.98% 38.85% 39.86% 40.14%
EBIT Margin (%) 39.87% 28.34% 29.93% 13.83% 28.07% 33.16% 34.69% 35.63%
EBT Margin (%) 39.5% 27.42% 30.83% 16.2% 27.72% 34.64% 35.31% 35.69%
Net margin (%) 30.42% 23.34% 24.61% 11.88% 24.74% 27.85% 28.1% 28.54%
FCF margin (%) 31,181.9% -4,829.54% 15,029.76% 21,555.98% 12,920.78% 18,349.34% 21,169.97% 22,247.54%
FCF / Net Income (%) 102,521.45% -20,688.64% 61,068.54% 181,411.45% 52,235.83% 65,888.39% 75,341.14% 77,946.32%

Profitability

        
ROA 10.7% 9.22% 4.31% 2.14% 4.75% 6.79% 7.22% 7.55%
ROE 16.5% 12.93% 5.07% 2.46% 5.94% 8.44% 9.16% 9.59%

Financial Health

        
Leverage (Debt/EBITDA) - 0.27x 1.46x 1.28x 1.77x 1.04x 0.54x 0.18x
Debt / Free cash flow - -0x 0x 0x 0x 0x 0x 0x

Capital Intensity

        
CAPEX / Current Assets (%) 3.35% 4.87% 9.65% 3.8% 2.6% 4.03% 3.92% 2.92%
CAPEX / EBITDA (%) 6.52% 12.73% 23.41% 14.84% 7.43% 10.36% 9.84% 7.28%
CAPEX / FCF (%) 0.01% -0.1% 0.06% 0.02% 0.02% 0.02% 0.02% 0.01%

Items per share

        
Cash flow per share 1 5,596 5.448 3,282 3,996 2,785 8,638 9,671 11,008
Change - -99.9% 60,152.17% 21.75% -30.32% 210.23% 11.95% 13.83%
Dividend per Share 1 628.9 - 436.1 686.8 714.3 751.8 783.1 820.6
Change - - - 57.5% 4% 5.26% 4.16% 4.79%
Book Value Per Share 1 24,186 26,200 71,472 77,898 74,169 81,415 88,138 96,076
Change - 8.32% 172.8% 8.99% -4.79% 9.77% 8.26% 9.01%
EPS 1 3,515 3,362 3,273 1,873 4,438 6,608 7,702 8,707
Change - -4.36% -2.65% -42.79% 136.99% 48.89% 16.56% 13.06%
Nbr of stocks (in thousands) 166,178 164,313 159,160 235,088 229,737 228,435 228,435 228,435
Announcement Date 16/02/22 03/03/23 29/02/24 25/02/25 04/02/26 - - -
1KRW
Estimates
2026 *2027 *
P/E 27.5x 23.6x
PBR 2.23x 2.06x
EV / Sales 7.91x 6.76x
Yield 0.41% 0.43%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
181,400.00KRW
Average target price
267,786.94KRW
Spread / Average Target
+47.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
  4. Financials Celltrion, Inc.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!